Comparison of Indian clinical practice guidelines for the management of hypertension with the World Health Organization, International Society of Hypertension, American, and European guidelines
Hypertension is the leading risk factor for preventable cardiovascular diseases and all-cause mortality globally, with majority of the hypertension-attributed deaths occurring in low- and middle-income countries like India. Several international and national clinical practice guidelines (CPGs) provi...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | Indian Heart Journal |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0019483223004789 |
| _version_ | 1797267186575736832 |
|---|---|
| author | Gautam Satheesh Rupasvi Dhurjati Jayagopal Pathiyil Balagopalan Padinhare P. Mohanan Abdul Salam |
| author_facet | Gautam Satheesh Rupasvi Dhurjati Jayagopal Pathiyil Balagopalan Padinhare P. Mohanan Abdul Salam |
| author_sort | Gautam Satheesh |
| collection | DOAJ |
| description | Hypertension is the leading risk factor for preventable cardiovascular diseases and all-cause mortality globally, with majority of the hypertension-attributed deaths occurring in low- and middle-income countries like India. Several international and national clinical practice guidelines (CPGs) provide evidence-informed recommendations to achieve optimal control. CPGs produced by the World Health Organization, International Society for Hypertension, American (AHA/ACC-2017), and European (ESC/ESH-2018) are “major” as they are widely used and are highly cited. We compared the main recommendations for the pharmacological management of hypertension among the major CPGs and the two existing Indian CPGs for similarities and shortcomings. Several deviations from the major CPGs were observed among Indian CPGs. Important shortcomings pertain to Indian CPGs’ low priority for initial combination therapy and the use of single pill combinations. Having multiple CPGs providing conflicting recommendations might discourage the adoption of evidence-based practices. There is a need for updating Indian CPGs based on up-to-date evidence. |
| first_indexed | 2024-04-25T01:12:35Z |
| format | Article |
| id | doaj.art-80621e7c87a4466da1c770f7dc56dfff |
| institution | Directory Open Access Journal |
| issn | 0019-4832 |
| language | English |
| last_indexed | 2024-04-25T01:12:35Z |
| publishDate | 2024-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Indian Heart Journal |
| spelling | doaj.art-80621e7c87a4466da1c770f7dc56dfff2024-03-10T05:11:10ZengElsevierIndian Heart Journal0019-48322024-01-0176169Comparison of Indian clinical practice guidelines for the management of hypertension with the World Health Organization, International Society of Hypertension, American, and European guidelinesGautam Satheesh0Rupasvi Dhurjati1Jayagopal Pathiyil Balagopalan2Padinhare P. Mohanan3Abdul Salam4The George Institute for Global Health, Hyderabad, Telangana, IndiaThe George Institute for Global Health, Hyderabad, Telangana, IndiaDepartment of Cardiology, Lakshmi Hospital, Palakkad, Kerala, IndiaDepartment of Cardiology, West Fort Hi-Tech Hospital, Thrissur, Kerala, IndiaThe George Institute for Global Health, Hyderabad, Telangana, India; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia; Prasanna School of Public Health, Manipal Academy of Higher Education, India; Corresponding author. Cardiovascular Research, 401, 4th Floor, Shangrila Plaza, Plot No.14, Road No. 2, Banjara Hills, Hyderabad, Telangana, India.Hypertension is the leading risk factor for preventable cardiovascular diseases and all-cause mortality globally, with majority of the hypertension-attributed deaths occurring in low- and middle-income countries like India. Several international and national clinical practice guidelines (CPGs) provide evidence-informed recommendations to achieve optimal control. CPGs produced by the World Health Organization, International Society for Hypertension, American (AHA/ACC-2017), and European (ESC/ESH-2018) are “major” as they are widely used and are highly cited. We compared the main recommendations for the pharmacological management of hypertension among the major CPGs and the two existing Indian CPGs for similarities and shortcomings. Several deviations from the major CPGs were observed among Indian CPGs. Important shortcomings pertain to Indian CPGs’ low priority for initial combination therapy and the use of single pill combinations. Having multiple CPGs providing conflicting recommendations might discourage the adoption of evidence-based practices. There is a need for updating Indian CPGs based on up-to-date evidence.http://www.sciencedirect.com/science/article/pii/S0019483223004789HypertensionClinical practice guidelinesPharmacological managementIndiaEvidence-based medicine |
| spellingShingle | Gautam Satheesh Rupasvi Dhurjati Jayagopal Pathiyil Balagopalan Padinhare P. Mohanan Abdul Salam Comparison of Indian clinical practice guidelines for the management of hypertension with the World Health Organization, International Society of Hypertension, American, and European guidelines Indian Heart Journal Hypertension Clinical practice guidelines Pharmacological management India Evidence-based medicine |
| title | Comparison of Indian clinical practice guidelines for the management of hypertension with the World Health Organization, International Society of Hypertension, American, and European guidelines |
| title_full | Comparison of Indian clinical practice guidelines for the management of hypertension with the World Health Organization, International Society of Hypertension, American, and European guidelines |
| title_fullStr | Comparison of Indian clinical practice guidelines for the management of hypertension with the World Health Organization, International Society of Hypertension, American, and European guidelines |
| title_full_unstemmed | Comparison of Indian clinical practice guidelines for the management of hypertension with the World Health Organization, International Society of Hypertension, American, and European guidelines |
| title_short | Comparison of Indian clinical practice guidelines for the management of hypertension with the World Health Organization, International Society of Hypertension, American, and European guidelines |
| title_sort | comparison of indian clinical practice guidelines for the management of hypertension with the world health organization international society of hypertension american and european guidelines |
| topic | Hypertension Clinical practice guidelines Pharmacological management India Evidence-based medicine |
| url | http://www.sciencedirect.com/science/article/pii/S0019483223004789 |
| work_keys_str_mv | AT gautamsatheesh comparisonofindianclinicalpracticeguidelinesforthemanagementofhypertensionwiththeworldhealthorganizationinternationalsocietyofhypertensionamericanandeuropeanguidelines AT rupasvidhurjati comparisonofindianclinicalpracticeguidelinesforthemanagementofhypertensionwiththeworldhealthorganizationinternationalsocietyofhypertensionamericanandeuropeanguidelines AT jayagopalpathiyilbalagopalan comparisonofindianclinicalpracticeguidelinesforthemanagementofhypertensionwiththeworldhealthorganizationinternationalsocietyofhypertensionamericanandeuropeanguidelines AT padinharepmohanan comparisonofindianclinicalpracticeguidelinesforthemanagementofhypertensionwiththeworldhealthorganizationinternationalsocietyofhypertensionamericanandeuropeanguidelines AT abdulsalam comparisonofindianclinicalpracticeguidelinesforthemanagementofhypertensionwiththeworldhealthorganizationinternationalsocietyofhypertensionamericanandeuropeanguidelines |